Literature DB >> 28382113

Analytical considerations for the biochemical assessment of vitamin D status.

Lewis Couchman1, Cajetan F Moniz2.   

Abstract

The most widely used and clinically accepted biochemical marker for assessing vitamin D status is the total serum 25-hydroxyvitamin D [25(OH)D] concentration. Despite the analysis of 25(OH)D dating back to the early 1970s, modern analytical techniques still exhibit significant interassay variability due to varying concentrations of other related vitamin D metabolites and sample-to-sample matrix differences. It is important for clinicians requesting 25(OH)D analyses to understand these issues and limitations, and where necessary to confront laboratories for details of analytical methods used. The availability of reference measurement procedures for 25(OH)D based on liquid chromatography and tandem mass spectrometry, whilst not intended for routine clinical sample analysis, should be utilized to improve assay harmonization and reduce interlaboratory variability. Laboratories should also be forthcoming with details of subscriptions to external quality assessment schemes and assay traceability. As well as discussing the reasons for ongoing assay variability for 25(OH)D, this short review will also briefly discuss other assays related to the assessment of vitamin D status, including parathyroid hormone, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D and vitamin D binding proteins.

Entities:  

Keywords:  1,25-dihydroxyvitamin D; 24,25-dihydroxyvitamin D; 25-hydroxyvitamin D; LC-MS/MS; Vitamin D; immunoassay; vitamin D binding protein; vitamin D status

Year:  2017        PMID: 28382113      PMCID: PMC5367642          DOI: 10.1177/1759720X17692500

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


  50 in total

1.  Does the presence of 3-epi-25OHD3 affect the routine measurement of vitamin D using liquid chromatography tandem mass spectrometry?

Authors:  Brian Keevil
Journal:  Clin Chem Lab Med       Date:  2011-10-20       Impact factor: 3.694

2.  C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status.

Authors:  Ravinder J Singh; Robert L Taylor; G Satyanarayana Reddy; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 4.  Relative value of 25(OH)D and 1,25(OH)2D measurements.

Authors:  Paul Lips
Journal:  J Bone Miner Res       Date:  2007-11       Impact factor: 6.741

5.  Assessing vitamin D status: time for a rethink?

Authors:  Graham D Carter; Karen W Phinney
Journal:  Clin Chem       Date:  2014-02-19       Impact factor: 8.327

6.  Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency.

Authors:  Paweł Płudowski; Elżbieta Karczmarewicz; Milan Bayer; Graham Carter; Danuta Chlebna-Sokół; Justyna Czech-Kowalska; Romuald Dębski; Tamas Decsi; Anna Dobrzańska; Edward Franek; Piotr Głuszko; William B Grant; Michael F Holick; Liudmila Yankovskaya; Jerzy Konstantynowicz; Janusz B Książyk; Krystyna Księżopolska-Orłowska; Andrzej Lewiński; Mieczysław Litwin; Szimonetta Lohner; Roman S Lorenc; Jacek Lukaszkiewicz; Ewa Marcinowska-Suchowierska; Andrzej Milewicz; Waldemar Misiorowski; Michał Nowicki; Vladyslav Povoroznyuk; Piotr Rozentryt; Ema Rudenka; Yehuda Shoenfeld; Piotr Socha; Bogdan Solnica; Mieczysław Szalecki; Marek Tałałaj; Szabolcs Varbiro; Michał A Żmijewski
Journal:  Endokrynol Pol       Date:  2013       Impact factor: 1.582

7.  Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD.

Authors:  Martin Kaufmann; J Christopher Gallagher; Munro Peacock; Karl-Peter Schlingmann; Martin Konrad; Hector F DeLuca; Rita Sigueiro; Borja Lopez; Antonio Mourino; Miguel Maestro; René St-Arnaud; Joel S Finkelstein; Donald P Cooper; Glenville Jones
Journal:  J Clin Endocrinol Metab       Date:  2014-03-26       Impact factor: 5.958

8.  A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D₃ and 25-hydroxyvitamin D₂ using isotope-dilution liquid chromatography-tandem mass spectrometry.

Authors:  Ekaterina M Mineva; Rosemary L Schleicher; Madhulika Chaudhary-Webb; Khin L Maw; Julianne C Botelho; Hubert W Vesper; Christine M Pfeiffer
Journal:  Anal Bioanal Chem       Date:  2015-05-13       Impact factor: 4.142

Review 9.  Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.

Authors:  Marijn Speeckaert; Guangming Huang; Joris R Delanghe; Youri E C Taes
Journal:  Clin Chim Acta       Date:  2006-05-12       Impact factor: 3.786

10.  1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D.

Authors:  Hector F Deluca; Jean M Prahl; Lori A Plum
Journal:  Arch Biochem Biophys       Date:  2010-10-18       Impact factor: 4.013

View more
  8 in total

1.  Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register.

Authors:  J Zugic Soares; R Pettersen; J Saltyte Benth; A B Knapskog; G Selbæk; N Bogdanovic
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  Impact of bone disease and pain in thalassemia.

Authors:  Antonio Piga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Osteoporosis in South-East Asian Countries.

Authors:  Subashini C Thambiah; Swan Sim Yeap
Journal:  Clin Biochem Rev       Date:  2020-02

Review 4.  Deconvoluting the Biological Roles of Vitamin D-Binding Protein During Pregnancy: A Both Clinical and Theoretical Challenge.

Authors:  Spyridon N Karras; Theocharis Koufakis; Hana Fakhoury; Kalliopi Kotsa
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-23       Impact factor: 5.555

5.  Chronic kidney disease is a main confounding factor for 25-vitamin D measurement.

Authors:  Hanna Karla Andrade Guapyassú Machado; Carolina Steller Wagner Martins; Vanda Jorgetti; Rosilene Motta Elias; Rosa Maria Affonso Moysés
Journal:  J Bras Nefrol       Date:  2019-09-26

Review 6.  Vitamin D Metabolism and Profiling in Veterinary Species.

Authors:  Emma A Hurst; Natalie Z Homer; Richard J Mellanby
Journal:  Metabolites       Date:  2020-09-15

Review 7.  Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine.

Authors:  Yechen Hu; Zhongcheng Wang; Liang Liu; Jianhua Zhu; Dongxue Zhang; Mengying Xu; Yuanyuan Zhang; Feifei Xu; Yun Chen
Journal:  Chem Sci       Date:  2021-05-25       Impact factor: 9.825

8.  A LC-MS method for 25-hydroxy-vitamin D3 measurements from dried blood spots for an epidemiological survey in India.

Authors:  Rashmi Lote-Oke; Jwala Pawar; Shriram Kulkarni; Prasanna Sanas; Neha Kajale; Ketan Gondhalekar; Vaman Khadilkar; Siddhesh Kamat; Anuradha Khadilkar
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.